Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Immunotech Biopharm Ltd ( (HK:6978) ) just unveiled an announcement.
Immunotech Biopharm Ltd has announced a discloseable transaction involving the subscription of structured deposit products from Bank of China Limited, with a total investment value of RMB120,000,000. This strategic financial move is subject to the notification and announcement requirements under the Listing Rules, highlighting the company’s efforts to manage its financial assets effectively and potentially enhance its financial returns through structured investments.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on the biotechnology sector. The company is involved in developing and providing biopharmaceutical products, with a market focus on innovative healthcare solutions.
Average Trading Volume: 1,252,525
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.94B
Find detailed analytics on 6978 stock on TipRanks’ Stock Analysis page.